UBS O'Connor’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,034
| Closed | -$481K | – | 453 |
|
|
2023
Q4 | $481K | Sell |
2,034
-1,177
| -37% | -$278K | 0.02% | 344 |
|
|
2023
Q3 | $629K | Hold |
3,211
| – | – | 0.01% | 363 |
|
|
2023
Q2 | $675K | Buy |
3,211
+158
| +5% | +$33.2K | 0.01% | 412 |
|
|
2023
Q1 | $616K | Buy |
+3,053
| New | +$616K | 0.01% | 438 |
|
|
2015
Q1 | – | Sell |
-3,440
| Closed | -$219K | – | 705 |
|
|
2014
Q4 | $219K | Buy |
+3,440
| New | +$219K | ﹤0.01% | 587 |
|